Benchmark initiated coverage of Abbott (ABT) with a Buy rating and $145 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk
- Abbott added to US Conviction List at Goldman Sachs
- DexCom assumed with Perform from Outperform at Oppenheimer
- Medtronic’s MiniMed 780G System cleared by FDA for Type 1 and 2 diabetes
- Abbott’s Navitor TAVI system receives CE Mark in Europe